Analyst Price Targets — A
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 6, 2026 12:38 pm | Vijay Kumar | Evercore ISI | $148.00 | $128.34 | TheFly | Agilent price target raised to $148 from $144 at Evercore ISI |
| June 11, 2026 9:50 am | David Westenberg | Piper Sandler | $150.00 | $131.62 | TheFly | Agilent initiated with a Neutral at Piper Sandler |
| June 3, 2026 9:27 am | Sidharth Sahoo | HSBC | $165.00 | $135.04 | TheFly | Agilent price target lowered to $165 from $180 at HSBC |
| May 28, 2026 12:35 pm | — | RBC Capital | $155.00 | $133.51 | TheFly | Agilent price target raised to $155 from $153 at RBC Capital |
| May 28, 2026 10:48 am | — | Robert W. Baird | $158.00 | $115.83 | TheFly | Agilent price target raised to $158 from $156 at Baird |
| May 28, 2026 10:22 am | Brandon Couillard | Wells Fargo | $160.00 | $115.83 | StreetInsider | Agilent (A) PT Lowered to $160 at Wells Fargo |
| May 26, 2026 8:12 pm | Dan Leonard | RBC Capital | $153.00 | $115.08 | TheFly | Agilent initiated with an Outperform at RBC Capital |
| May 26, 2026 10:48 am | Catherine Ramsey Schulte | Robert W. Baird | $156.00 | $114.96 | TheFly | Agilent price target raised to $156 from $155 at Baird |
| April 14, 2026 10:41 am | Luke Sergott | Barclays | $140.00 | $117.52 | TheFly | Agilent price target lowered to $140 from $150 at Barclays |
| March 9, 2026 1:27 pm | — | Fermium Research | $150.00 | $114.21 | StreetInsider | BofA Securities Reiterates Neutral Rating on Agilent (A) following Biocare Medical acquisition announcement |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for A

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the PD‑L1 IHC 28‑8 pharmDx assay as a companion diagnostic to identify patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma who may be eligible for treatment with OPDIVO®…

A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a…
[url="]Alpha and Omega Semiconductor Limited[/url] (AOS) (Nasdaq: AOSL), a designer, developer, and global supplier of a broad range of discrete power devices,

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
